| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/13/2003 | WO2003011200A2 Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity |
| 02/13/2003 | WO2002101388A3 Assay for predeicting cell activity |
| 02/13/2003 | WO2002096947A8 The lectin-like domain of thrombomodulin and its therapeutic use |
| 02/13/2003 | WO2002092794A3 Isolation method of mesenchymal cells |
| 02/13/2003 | WO2002088328A8 Method for generating highly active human dendritic cells from monocytes |
| 02/13/2003 | WO2002080849A3 Chemotherapeutic induction of egr-1 promoter activity |
| 02/13/2003 | WO2002078721A9 Two-constituent compositions for the in situ production of cell transplants that comprise fibroblasts and keratinocytes |
| 02/13/2003 | WO2002074345B1 Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules |
| 02/13/2003 | WO2002070648A3 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 02/13/2003 | WO2002069907A3 Anti-neovasculature preparations for cancer |
| 02/13/2003 | WO2002065992A3 A cell therapy method for the treatment of tumors |
| 02/13/2003 | WO2002048321A3 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect |
| 02/13/2003 | WO2002040688A9 Maize yellow stripe1 and related genes |
| 02/13/2003 | WO2002038805A3 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 02/13/2003 | WO2002037101A3 A method to determine an engrafting cell dose of hematopoietic stem cell transplant units |
| 02/13/2003 | WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | WO2002026778A3 Isolated peptides which bind to hla-c molecules and uses thereof |
| 02/13/2003 | WO2002024874A3 Methods for preparing interferon producing dentitric cells |
| 02/13/2003 | WO2002018443A3 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 02/13/2003 | WO2002016594A3 Methods and reagents for molecular cloning |
| 02/13/2003 | WO2001067855A3 Transgenic mice containing targeted gene disruptions |
| 02/13/2003 | US20030033636 Expression of eukaryotic peptides in plant plastids |
| 02/13/2003 | US20030033629 RecA proteins |
| 02/13/2003 | US20030033622 Generation of trangeenic insects; obtain embryo, inject with transposable expression vector coding heterologous protein, detect insertion of sequences into embryonic genome, expression of reporter molecule indicates insertion |
| 02/13/2003 | US20030033022 Cartilage repair and regeneration device and method |
| 02/13/2003 | US20030033021 Cartilage repair and regeneration scaffold and method |
| 02/13/2003 | US20030032946 Artificial synapse chip interface for electronic prosthetic retina |
| 02/13/2003 | US20030032792 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of gastrointestinal, crohn's, inflammatory bowel, diabetes and cancer, |
| 02/13/2003 | US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders |
| 02/13/2003 | US20030032790 Mammal use as model in the diagnosis, prevention and treatment of hypercholesteremia or hyperlipoproteinemia, obesity, diabetes, tumors, anorexia, hyperlipidemia, lipoprotein defects, osteoporosis, arthritis and tumors |
| 02/13/2003 | US20030032781 Antibody for use in the treatment of cancer |
| 02/13/2003 | US20030032777 Precursor polypeptide of phytosulfokine derived from Arabidopsis thaliana and a gene encoding said polypeptide |
| 02/13/2003 | US20030032769 Second mammalian tankyrase |
| 02/13/2003 | US20030032613 Novel adenovirus gene therapy vehicle and cell line |
| 02/13/2003 | US20030032187 Selective antibody targeting of undifferentiated stem cells |
| 02/13/2003 | US20030032186 Method for stable chromosomal multi-copy integration of genes |
| 02/13/2003 | US20030032185 Cell culture for use in the generation of cells for human therapeutics and diagnostics |
| 02/13/2003 | US20030032184 Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders |
| 02/13/2003 | US20030032183 Induction of preferential stem cell differentiation; obtain nutrient broths, inoculate with cells, mix with modulator, propagate and recover cells |
| 02/13/2003 | US20030032182 Propagation of liver cells; generate nutrient broths, incubate with modulator, mix with hepatocytes, propagate and recover liver cells |
| 02/13/2003 | US20030032181 Generation of radial glial cells for use in the treatment of nervous system disorders; obtain neuronal stem cells, incubate with modulator, propagate cells, recover glial cells |
| 02/13/2003 | US20030032180 Regeneration of mammalian cells; obtain mammalian cells, incubate with expression vector, transform cells, inoculate culture, recover cells |
| 02/13/2003 | US20030032179 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/13/2003 | US20030032178 In vitro propagation of embryonic stem cells |
| 02/13/2003 | US20030032177 Cell maintenance and proliferation |
| 02/13/2003 | US20030032176 Helper-free stocks of recombinant adeno-associated virus vectors |
| 02/13/2003 | US20030032169 Nucleotide sequences coding polypeptide for use in the treatment of cancer, skin and vision defects |
| 02/13/2003 | US20030032166 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 02/13/2003 | US20030032160 Nucleotide sequences coding protein for use in treatment of cancer, inflammation, arthritis and psoriasis |
| 02/13/2003 | US20030032156 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 02/13/2003 | US20030032155 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032144 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 02/13/2003 | US20030032138 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032135 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032119 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032098 Bone morphogenic protein |
| 02/13/2003 | US20030032097 DNA encoding human vanilloid receptor VR3 |
| 02/13/2003 | US20030032095 Novel nucleic acid sequences encoding human semaphorin-like polypeptides |
| 02/13/2003 | US20030032086 Mixture for use as tool in propagation of nucleotide sequences |
| 02/13/2003 | US20030032085 An expression cassette comprising a transcriptional initiation region, consisting of a 5' non-coding region regulating the transcription of patched protein, a marker gene, and a transcriptional termination region |
| 02/13/2003 | US20030032071 Cell isolation and screening device and method of using same |
| 02/13/2003 | US20030032063 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032062 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032057 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032050 Methods and compositions using peptide-pulsed dendritic cells for stimulating cytotoxic T lymphocytes specific for tumor cells or virus-infected cells |
| 02/13/2003 | US20030032032 Diagnosing viral brain disorders; obtain sample nucleic acids, incubate with marker probe, denature, hybridize, detect signal from probe, presence of signal indicates viral infection |
| 02/13/2003 | US20030032023 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 02/13/2003 | US20030032018 Nucleotide sequences coding preferential plypeptide for use in the diagnosis and treatment of hypertension, hypotension, heart disease, asthma, and the like. |
| 02/13/2003 | US20030032006 A PC12 cell quiescently infected with a human herpes simplex 2 virus (HSV-2); determining the ability of a test reagent to suppress virus reactivation from a quiescently-infected PC12 cells |
| 02/13/2003 | US20030032002 Screening cells for preferential cell activity; obtain cells insert into monitoring apparatus, detect preferential activity, separate cells expressing preferential activity |
| 02/13/2003 | US20030031999 Determining the translational efficiency of an individual codon in a cell; obtain cell, transform with expression vector, express vector, monitor gene expression and translation |
| 02/13/2003 | US20030031998 Cryopreservation of diverse plant cells |
| 02/13/2003 | US20030031738 Saponin mixtures and compounds are isolated from the species Acacia victoriae; e.g., glycosides of acacic or oleanolic acid; control of cell apoptosis and cytotoxicity; antitumor, -carcinogenic, -inflammatory and -proliferative agents |
| 02/13/2003 | US20030031696 Artificial salivary gland |
| 02/13/2003 | US20030031695 Administering isolated human mesenchymal stem cells with a ceramic material or matrix of resorbable biopolymer which supports differentiation into osteogenic lineage |
| 02/13/2003 | US20030031680 Genes and proteins can be used in making transgenic animals and in assays designed to determine the likelihood of an individual developing cardiomyopathy |
| 02/13/2003 | US20030031679 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 02/13/2003 | US20030031664 For therapy of pulmonary embolism, myocardial infarction, thrombosis or stroke |
| 02/13/2003 | US20030031663 Immunogenic polypeptides for inducing anti-self IgE responses |
| 02/13/2003 | US20030031657 Stem cells and their use in transplantation |
| 02/13/2003 | US20030031656 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response |
| 02/13/2003 | US20030031654 Prohormone convertase transformed cells and polypeptide synthesis |
| 02/13/2003 | US20030031652 Systems and methods for inducing mixed chimerism |
| 02/13/2003 | US20030031651 Methods and reagents for cell transplantation |
| 02/13/2003 | US20030031649 Gene therapy to promote angiogenesis |
| 02/13/2003 | US20030029086 Floral packaging material having great masters prints thereon |
| 02/13/2003 | CA2838062A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | CA2808598A1 Antigenic polypeptides |
| 02/13/2003 | CA2780120A1 Immunologically significant herpes simplex virus antigens and methods for using same |
| 02/13/2003 | CA2456229A1 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 02/13/2003 | CA2456092A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 02/13/2003 | CA2455918A1 Hagfish cathelin-associated antimicrobial peptides and genes |
| 02/13/2003 | CA2455700A1 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/13/2003 | CA2455462A1 Androgen receptor knock-out transgenic animals |
| 02/13/2003 | CA2455365A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | CA2455327A1 Generation of fully mature and stable dendritic cells from leukaphereses products for clinical applications |
| 02/13/2003 | CA2455237A1 Compositions and methods for generating chimeric heteromultimers |
| 02/13/2003 | CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity |